Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Researchers find DMT an ‘increasingly popular’ psychedelic drug

by Eric W. Dolan
November 30, 2013
in Psychopharmacology
Share on TwitterShare on Facebook

Dimethyltryptamine moleculeThe illegal drug known as N,N-dimethyltryptamine (DMT) appears to be increasing in popularity, but is relatively safe, according to research published in the Journal of Psychopharmacology in November.

“The ratio of users for whom DMT was the last new drug versus those who reported lifetime DMT use was higher than ketamine, LSD and magic mushrooms, suggesting that it may be an increasingly popular substance for those seeking an alternative to traditionally available hallucinogens,” Dr. Adam R. Winstock of King’s College London and his colleagues wrote in the study.

DMT was first synthesized by the chemist Richard H. F. Manske in 1931. The drug’s powerful psychedelic properties were not scientifically documented until psychiatrist Stephen Szára studied DMT in the mid-1950s. Researchers later discovered the drug occurred naturally in the human body.

Though the scientific institutions of the West only recently discovered DMT, the drug was the key component of a sacred brew called ayahausca or yage that had a long history of use by South American tribes.

Winstock and his colleagues used the Global Drug Survey to compare DMT with ketamine, LSD and magic mushrooms. The survey included more than 22,000 respondents from around the world. About two percent, or 472 participants, reported that DMT was the last new drug they had tried.

Those who recently started using the drug were more likely to be younger, male and currently in education when compared with those who never used DMT.

For all the psychedelic substances, the most common source was a friend. A drug dealer was the second most common source.

DMT users said the drug provided “a short, intense and pleasurable experience with negligible negative effects.”

Google News Preferences Add PsyPost to your preferred sources

The vast majority smoked DMT and for most people the effects only lasted about 15 minutes. The majority of users also rated the effect of DMT as stronger than ketamine, magic mushrooms and LSD.

“Such potency of effect should prompt novice users to take significant care and advice when first using this drug since the rapid onset of an intense psychedelic effect may be unpleasant,” the researchers noted.

Few people felt an urge to use more of the drug. The researchers concluded that DMT “has a reasonable safety profile, with few users reporting significant negative effects when high or following an episode of use.” The median lethal dose of DMT in humans is estimated to be about 560 mg, which is 20 times a normal dose.

The harms associated with the drug are due to “bad trips,” or disturbing hallucinatory experiences. Some users also reported respiratory irritation.

“Like other psychedelic substances, DMT’s profound effects on consciousness may limit its appeal to the wider population and likely prevent habitual use, except in those who use it in within a religious context,” the researchers said.

The drug’s subjective effects were featured in the cult film Enter the Void. Watch below:

Previous Post

Who are you looking at? Why women recognise more faces than men

Next Post

Time flies when you are looking at an unattractive face

RELATED

Alcohol dampens reactivity to psychological stress, especially for uncertain stressors
Addiction

Researchers identify personality traits that predict alcohol relapse after treatment

March 12, 2026
Moderate coffee consumption during pregnancy unlikely to cause ADHD in children
Anxiety

Two to three cups of coffee a day may protect your mental health

March 11, 2026
New analysis shows ideology, not science, drove the global prohibition of psychedelics
Psychedelic Drugs

New analysis shows ideology, not science, drove the global prohibition of psychedelics

March 10, 2026
Democrats dislike Republicans more than Republicans dislike Democrats, studies find
Ayahuasca

A single dose of DMT reverses depression-like symptoms in mice by repairing brain circuitry

March 8, 2026
Stimulant medications normalize brain structure in children with ADHD, study suggests
ADHD Research News

Long-term ADHD medication use does not appear to permanently alter the developing brain

March 5, 2026
Hemp-derived cannabigerol shows promise in reducing anxiety — and maybe even improving memory
Alcohol

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

March 5, 2026
New psychology research flips the script on happiness and self-control
Cannabis

Exploring the motivations for cannabis use during sex

March 4, 2026
Chocolate lovers’ brains: How familiarity influences reward processing
Cognitive Science

A single dose of cocoa flavanols improves cognitive performance during aerobic exercise

March 4, 2026

STAY CONNECTED

LATEST

A newly discovered brain cluster acts as an on and off switch for sex differences

Researchers identify personality traits that predict alcohol relapse after treatment

New study links the fatigue of depression to overworked cellular power plants

New study reveals risk factors for suicidal thoughts in people with gambling problems

Texas migrant buses boosted Donald Trump’s vote share in targeted cities

Genetic tendency for impulsivity is linked to lower education and earlier parenthood

The bystander effect applies to virtual agents, new psychology research shows

The orgasm face decoded: The intriguing science of sexual climax

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc